Sabra Health Care REIT (NASDAQ:SBRA) Stock Price Expected to Rise, Scotiabank Analyst Says

Sabra Health Care REIT (NASDAQ:SBRA - Get Free Report) had its target price raised by analysts at Scotiabank from $18.00 to $19.00 in a report issued on Monday,Benzinga reports. The brokerage currently has a "sector perform" rating on the real estate investment trust's stock. Scotiabank's price target indicates a potential upside of 5.94% from the stock's previous close.

Separately, Truist Financial increased their price target on shares of Sabra Health Care REIT from $17.00 to $18.00 and gave the company a "hold" rating in a report on Tuesday, March 18th. Three research analysts have rated the stock with a hold rating, three have given a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $19.50.

Sabra Health Care REIT Trading Down 1.4%

Shares of Sabra Health Care REIT stock traded down $0.26 on Monday, hitting $17.94. 983,123 shares of the company's stock traded hands, compared to its average volume of 2,153,000. The firm's 50-day moving average price is $17.39 and its two-hundred day moving average price is $17.46. The stock has a market capitalization of $4.27 billion, a PE ratio of 33.81, a price-to-earnings-growth ratio of 1.97 and a beta of 0.88. Sabra Health Care REIT has a one year low of $13.87 and a one year high of $20.03. The company has a debt-to-equity ratio of 0.88, a current ratio of 4.32 and a quick ratio of 4.16.

Sabra Health Care REIT (NASDAQ:SBRA - Get Free Report) last announced its earnings results on Monday, May 5th. The real estate investment trust reported $0.37 earnings per share for the quarter, topping analysts' consensus estimates of $0.36 by $0.01. Sabra Health Care REIT had a net margin of 18.02% and a return on equity of 4.60%. The firm had revenue of $183.54 million during the quarter, compared to analyst estimates of $180.23 million. During the same period in the prior year, the business earned $0.35 EPS. The company's revenue for the quarter was up 10.1% compared to the same quarter last year. On average, research analysts expect that Sabra Health Care REIT will post 1.45 EPS for the current fiscal year.

Institutional Inflows and Outflows

Several hedge funds have recently made changes to their positions in SBRA. VSM Wealth Advisory LLC acquired a new stake in shares of Sabra Health Care REIT during the 4th quarter worth approximately $26,000. UMB Bank n.a. boosted its position in Sabra Health Care REIT by 379.6% in the first quarter. UMB Bank n.a. now owns 2,048 shares of the real estate investment trust's stock valued at $36,000 after buying an additional 1,621 shares in the last quarter. Assetmark Inc. boosted its position in Sabra Health Care REIT by 33.4% in the fourth quarter. Assetmark Inc. now owns 2,618 shares of the real estate investment trust's stock valued at $45,000 after buying an additional 656 shares in the last quarter. Fifth Third Bancorp boosted its position in Sabra Health Care REIT by 110.3% in the first quarter. Fifth Third Bancorp now owns 3,835 shares of the real estate investment trust's stock valued at $67,000 after buying an additional 2,011 shares in the last quarter. Finally, GF Fund Management CO. LTD. acquired a new stake in Sabra Health Care REIT in the fourth quarter valued at approximately $74,000. 99.40% of the stock is owned by institutional investors.

About Sabra Health Care REIT

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.